Yelda Jozaghi*1, Mark E Zafereo*1, Nancy D Perrier2, Jennifer R Wang1, Elizabeth Grubbs2, Neil D Gross1, Sarah Fisher2, Erich M Sturgis1, Ryan P Goepfert1, Stephen Y Lai1, Conor Best3, Naifa L Busaidy3, Maria E Cabanillas3, Ramona Dadu3, Robert F Gagel3, Mouhammed A Habra3, Mimi I Hu3, Camilo Jimenez3, Steven I Sherman3, Sonali Thosani3, Jeena Varghese3, Steven G Waguespack3, Steven Weitzman3, Anita K Ying3, Paul H Graham2. *Co-first authors
1Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.2Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.3Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
This work was not funded.
All authors participated in the manuscript drafting or review process.
This work has not been presented at any meetings or conferences.
Corresponding author: Mark E Zafereo 1515 Holcombe Boulevard Unit FCT 10.6008 Houston, Texas 77030 713-563-9683 MZafereo@mdanderson.org
Key words: Coronavirus, COVID, Endocrine, Surgery, Guideline.